News

The Wall Street Journal: J&N COVID vaccine shows promising signs of protecting against delta variant

Johnson & Johnson’s COVID-19 vaccine showed promising signs in a small laboratory study of protecting against the Delta variant spreading across the U.S. and other countries, the company said.

In laboratory testing, the vaccine triggered strong levels of neutralizing antibodies in blood samples taken from eight vaccinated people, J&J
JNJ,
+0.74%

said Thursday.

The positive performance adds to a growing set of evidence indicating currently authorized COVID-19 vaccines can safeguard against the Delta variant, which appears to be more contagious than earlier strains.

How well the J&J shot fares against the Delta variant has been closely watched by health authorities around the world.

An expanded version of this report appears onWSJ.com.

Also popular on WSJ.com:

Problems with the Miami-area condo: A visual analysis.

Another respiratory virus is spreading as U.S. gets back to pre-COVID-19 life.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News